近日，均普智能向特定对象发行股票的申请获上交所受理，公司此次拟募集不超过10.34亿元投入机器人及医疗健康等热门领域。然而公司上市后业绩持续 承压，近三年扣非净利润持续亏损，且存在较大的商誉。而公司IPO的两个募投项目已经过两次延期，当前也尚未达到可使用状态。 | | | | 半 V : | | --- | --- | --- | --- | | 序号 | 项目 | 项目总投资 | 募集资金金额 | | | 智能机器人研发及产业化项目 | 62.333.36 | 55,058.42 | | 2 | 医疗健康智能设备应用及技术服务能 | 11.435.00 | 7.305.00 | | | 力提升项目 | | | | 3 | 信息化建设项目 | 13.335.00 | 11,030.00 | | র্ব | 补充流动资金项目 | 30.000.00 | 30,000.00 | | | 总计 | 117.103.36 | 103.393.42 | 拟募资超10亿加码机器人业务，公司股价曾一年最高涨超3倍 1月15日晚间，均普智能公告称公司收到上海证券交易所出具的《关于受理宁波均普智能制造股份有限公司科创板上市公司 ...

每经记者｜闫峰峰 每经编辑｜吴永久 近日，均普智能向特定对象发行股票的申请获上交所受理，公司此次拟募集不超过10.34亿元投入机器人及医疗健康等热门领域。然而公司上市后业绩持续 承压，近三年扣非净利润持续亏损，且存在较大的商誉。而公司IPO的两个募投项目已经过两次延期，当前也尚未达到可使用状态。 拟募资超10亿加码机器人业务，公司股价曾一年最高涨超3倍 1月15日晚间，均普智能公告称公司收到上海证券交易所出具的《关于受理宁波均普智能制造股份有限公司科创板上市公司发行证券申请的通知》。上海证 券交易所对公司报送的科创板上市公司发行证券的募集说明书及相关申请文件进行了核对，决定予以受理并依法进行审核。 根据均普智能向特定对象发行股票募集说明书，公司拟向不超过35名特定投资者发行股票募集资金不超过10.34亿元。 均普智能本次募资拟投向机器人与医疗健康等热门赛道。根据募集说明书，本次募投用于智能机器人研发及产业化、医疗健康智能设备应用及技术服务能力 提升、信息化建设及补充流动资金等4个项目。 其中智能机器人研发及产业化项目拟投入5.51亿元，主要聚焦具身智能机器人技术研发与产业化。公司表示，该项目将深化公司具身智能 ...

Core Viewpoint - Junsheng Group is leveraging embodied intelligence technology to enhance its position in the competitive landscape of intelligent manufacturing, focusing on AI integration across various sectors such as new energy vehicles and healthcare [1][4]. Group 1: Company Strategy and Innovation - Junsheng Group emphasizes innovation as a driving force for development, aligning closely with national strategic needs to stand out in a competitive market [2]. - The company is implementing a "full-dimensional penetration revolution" of AI technology, enhancing internal management systems and external smart factory ecosystems to improve production efficiency and safety [3][4]. - In the new energy vehicle sector, Junsheng Group's intelligent manufacturing equipment business generated revenue of 2.102 billion yuan, marking a year-on-year growth of 32.61% [3]. Group 2: Technological Advancements - Junsheng Group has developed a "visual AI" vertical model that has improved laser welding yield rates to over 95% in automotive sensor production lines [3]. - The company is also advancing in the healthcare sector, having established a complete assembly process for domestic insulin pens and achieving zero error detection in syringe systems for a French pharmaceutical giant [3]. - The company is innovating in embodied intelligent robots, which can dynamically adjust operational strategies for flexible manufacturing, significantly reducing production changeover times [6]. Group 3: Ecosystem Development - Junsheng Group is building an industrial ecosystem for embodied intelligence, transitioning from isolated operations to collaborative efforts across the supply chain [7][8]. - The company has formed strategic partnerships with various organizations, including Zhejiang Hechuan and Jieka Robotics, to explore and cultivate domestic and international markets [8]. - Collaborations with top universities like Tsinghua University and Hong Kong University of Science and Technology are aimed at advancing core technologies and key components for intelligent robotics [8].